MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Teveten (eprosartan mesylate)

Company: SmithKline Beecham
Approval Status: Approved December 1997
Treatment for: hypertension
Areas: Cardiovascular / Cardiology; Diabetes / Endocrinology
Possible similar drugs: Teveten

| General Information | Mechanism of Action |


General Information

Teveten was approved for the treatment of hypertension, as either a monotherapy or for use in combination with other antihypertensives.


Mechanism of Action

Teveten is an angiotensin II antagonist.




< back to top

Teveten Drug Information

The Teveten drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.